6 terminated. 6 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 6 |
| Phase 3 | 2 | Terminated 2 |
Follow nitazoxanide: new trials by email Literature Review of nitazoxanide trials Research Report on nitazoxanide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 Nitazoxanide, Placebo Nitazoxanide, Ribavirin - SARS-CoV Infection, Covid19 | Phase 2 | Terminated | Rutgers, The State University of New Jersey | 7 | 2020-12-02 | 2022-05-05 |
| The Nitazoxanide Plus Atazanavir for COVID-19 Study Nitazoxanide and atazanavir/ritonavir, Standard of Care - Covid-19 | Phase 2 | Terminated | Obafemi Awolowo University | 57 | 2020-10-09 | 2022-03-02 |
| Catalysing the Containment of COVID-19 Nitazoxanide, Placebo - COVID-19 | Phase 2 / Phase 3 | Terminated | University of Cape Town | 322 | 2020-08-27 | 2022-08-16 |
| Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children Nitazoxanide, placebo - Gastroenteritis | Phase 2 / Phase 3 | Terminated | Telethon Kids Institute | 216 | 2014-11-01 | 2024-02-08 |
| Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza Nitazoxanide, Placebo - Influenza | Phase 2 | Terminated | Romark Laboratories L.C. | 79 | 2010-01-01 | 2018-04-05 |
| Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease Nitazoxanide, Placebo - Crohn's Disease | Phase 2 | Terminated | Romark Laboratories L.C. | 98 | 2005-08-01 | 2012-05-31 |
COVID-19 (3) · Severe Acute Respiratory Syndrome (2) · Coronavirus Infections (1) · Crohn Disease (1) · Gastroenteritis (1) · Influenza, Human (1)
Romark Laboratories L.C. (2) · Obafemi Awolowo University (1) · Rutgers, The State University of New Jersey (1) · Telethon Kids Institute (1) · University of Cape Town (1)
United States (3) · Australia (1) · Nigeria (1) · South Africa (1)
Jeffrey L Carson, MD (1) · Maria Carrion, MD (1) · Tom Snelling (1)